Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation.
Signe SørupBianka DarvalicsAzza Ahmed KhalilMarianne NordsmarkMette HæeFrede DonskovMads AgerbækLeo RussoDina OksenEmmanuelle BoutmyPatrice VerpillatDeirdre P Cronin-FentonPublished in: Clinical epidemiology (2021)
Most patients with advanced NSCLC, urothelial carcinoma, epithelial ovarian cancer, gastric adenocarcinoma and RCC had poor OS in an era where only a minority received PD-L1/PD-1 ICIs. This information on treatment patterns and survival is important as a benchmarking real-world standard before widespread use of ICIs.